1197938

Gadal Laboratories Inc. — FEI 3008611487

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
February 17, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Miami, FL (United States)